N@N

OSUR, LMNX, OPLK, MAXY, AROW, NANO Are Seasonally Ripe To Go Down In the Next Five Weeks

March 5, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ORASURE TECHNOLOGIES INC (NASDAQ:OSUR), Luminex Corp (NASDAQ:LMNX), OPLINK COMMUNICATIONS INC (NASDAQ:OPLK), Maxygen Inc (NASDAQ:MAXY), Arrow Financial Corp (NASDAQ:AROW), NANOMETRICS INC (NASDAQ:NANO) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     OSUR       ORASURE TECHNOLOGIES INC            -2.57%              75.00% (9 of 12)        Tuesday, March 6th 2012
     LMNX       Luminex Corp                        -2.63%              90.91% (10 of 11)       Tuesday, March 6th 2012
     OPLK       OPLINK COMMUNICATIONS INC           -4.23%              81.82% (9 of 11)        Tuesday, March 6th 2012
     MAXY       Maxygen Inc                         -2.99%              91.67% (11 of 12)       Wednesday, March 7th 2012
     AROW       Arrow Financial Corp                -1.63%              91.67% (11 of 12)       Tuesday, March 6th 2012
     NANO       NANOMETRICS INC                     -4.06%              75.00% (9 of 12)        Tuesday, March 6th 2012

ORASURE TECHNOLOGIES INC (NASDAQ:OSUR) - OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. Its products include OraQuick ADVANCE HIV-1/2, a point-of-care test for antibodies to the human immunodeficiency virus type 1 and type 2; OraQuick HCV, a point-of-care test for antibodies to the hepatitis C virus; OraSure, an oral fluid collection device for the detection of antibodies to HIV-1; and Intercept, an oral fluid collection device for oral fluid drugs of abuse testing. The company also offers MICRO-PLATE DOA Assays used to detect drugs in an oral fluid sample; Cryosurgical SystemsProfessional under the Histofreezer trade name for the removal of warts and other benign skin lesions; and Cryosurgical SystemsOTC for the removal of common and plantar warts. In addition, it develops OraQuick HIV-1/2 OTC, a point-of-care oral fluid HIV-1/2 test; Homogeneous DOA Assays; and OraQuick, a point-of-care testing platform. Further, the company sells immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid western blot HIV-1 confirmatory test; and Q.E.D., a rapid point-of-care saliva alcohol test. Additionally, it offers various diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types, and other medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The company markets its products through direct sales, strategic collaborations, and independent distributors to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians offices, and commercial and industrial entities in the United States and internationally. It has collaboration agreements with Merck & Co. Inc. and Roche Diagnostics. The company was founded in 1979 and is based in Bethlehem, Pennsylvania.

Luminex Corp (NASDAQ:LMNX) - Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for applications in the life sciences and diagnostic industries in the United States. It offers xMAP technology, an open architecture and multiplexing technology, which allows simultaneous analysis of up to 500 bioassays from a single drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres. The companys xMAP technology is used in various segments of the life sciences industry, which includes the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, protein analysis, and biomedical research. It operates in two segments, Technology and Assay. The Technology segment offers instruments, such as compact analyzers that integrate fluidics, optics, and digital signal processing, as well as peripheral components; FLEXMAP 3D system for use as a general laboratory instrument in life science research and diagnostics markets; and consumables comprising microspheres and sheath fluid. The Assay segment involves in the development and sale of assays on xMAP technology for use on Luminexs installed base of systems. It offers various assay products, which consists of a combination of chemical and biological reagents, and the companys proprietary bead technology used to perform diagnostic and research assays on samples. Luminex Corporation serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions. It has a collaboration agreement with Northrop Grumman Corporation. The company was founded in 1995 and is based in Austin, Texas.

OPLINK COMMUNICATIONS INC (NASDAQ:OPLK) - Oplink Communications, Inc. designs, manufactures, and sells optical networking components and subsystems worldwide. The company offers its services for optical networking components and subsystems that expand optical bandwidth, amplify optical signals, monitor and protect wavelength performance, redirect light signals, and provide signal transmission and reception within an optical network. Its product portfolio includes solutions for all-optical dense and coarse wavelength division multiplexing, optical amplification, switching and routing, monitoring and conditioning, and line transmission applications. The company also provides optical manufacturing solutions for the production and packaging of integrated optical subsystems and turnkey solutions based upon a customers specific product design and specifications. Its bandwidth creation products include wavelength expansion products, including dense wavelength division multiplexers (DWDM), coarse wavelength division multiplexers, band wavelength division multiplexers, and DWDM interleavers; and optical amplification products, including gain blocks, erbium doped fiber amplifiers, WDM pump/signal combiners, integrated hybrid components, WDM pump combiners, polarization beam combiners, isolators, and tap couplers. The company offers bandwidth management products, such as wavelength performance monitoring and protection products; optical switching and routing products; and wavelength conditioning products. In addition, it provides transmission products consisting of fiber optic modules, including fiber optic transmitters, receivers, transceivers, and transponders for long-haul networks, metropolitan area networks, local area networks, and fiber-to-the-home networks. The company markets its products through direct sales and distribution channels to telecommunications, data communications, and cable television equipment manufacturers. Oplink Communications was founded in 1995 and is headquartered in Fremont, California.

Maxygen Inc (NASDAQ:MAXY) - Maxygen, Inc., a biopharmaceutical company, focuses on developing improved versions of protein drugs. The company utilizes its MolecularBreeding directed evolution technology platform, along with ancillary technologies, and protein modification expertise to pursue the creation of biosuperior proteins. It engages in the discovery, and research and development of multiple protein pharmaceutical programs, including CTLA-4 Ig product candidates that are designed to be CTLA-4 Ig therapeutics for the treatment of an array of autoimmune disorders, including rheumatoid arthritis, and transplant rejection; and MAXY-G34 product candidates for the treatment of chemotherapy-induced neutropenia. The company also focuses on developing biocatalytic process technologies for pharmaceutical, energy, and industrial chemical applications. Maxygen, Inc. was founded in 1996 and is headquartered in Redwood City, California.

Arrow Financial Corp (NASDAQ:AROW) - Arrow Financial Corporation operates as the holding company for Glens Falls National Bank and Trust Company, and Saratoga National Bank and Trust Company that offer various commercial and consumer banking, and financial products in the United States. The company offers various deposit products, which include demand deposits, savings, NOW, and money market deposits. It engages in a range of lending activities, including commercial and industrial lending primarily to small and midsized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. Arrow Financial Corporation maintains an indirect lending program through sponsorship of automobile dealer programs under which, it purchases dealer paper primarily from dealers that meet pre-established specifications. The company, through its trust operations, provides retirement planning, trust, and estate administration services for individuals, pension, and profit-sharing; and employee benefit plan administration for corporations. In addition, it holds an insurance agency that specializes in selling and servicing group health care policies; operates as an investment adviser that advises the companys proprietary mutual funds; provides administrative and recordkeeping services for complex retirement plans; and holds a real estate investment trust. The company operates in Warren, Washington, Saratoga, Essex, and Clinton counties and surrounding areas. It owns 28 branch offices and leases 6 offices. The company was founded in 1851 and is headquartered in Glens Falls, New York.

NANOMETRICS INC (NASDAQ:NANO) - Nanometrics Incorporated provides high-performance process control metrology systems used primarily in the fabrication of semiconductors, high-brightness LEDs, data storage devices, and solar photovoltaics. Nanometrics automated and integrated metrology systems measure critical dimensions, device structures, overlay registration, topography, and various thin film properties, including film thickness as well as optical, electrical, and material properties. The companys process control solutions are deployed throughout the fabrication process, from front-end-of-line substrate manufacturing, to high-volume production of semiconductors and other devices, to advanced wafer-scale packaging applications. Its systems enable device manufacturers to improve yields, increase productivity and lower their manufacturing costs. The company was founded in 1975 and is headquartered in Milpitas, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641